Inclusion of Women, Children, the Elderly, and Individuals With Underlying Medical Conditions: Prioritizing Vulnerable Populations in Clinical Research
Abstract
For over 60 years, the National Institutes of Health (NIH)-funded Vaccine and Treatment Evaluation Units (VTEUs) have led national efforts in vaccine development, evaluation of novel treatment of infectious diseases, and pandemic preparedness. Although most VTEU research has been conducted in healthy adult volunteers, the VTEU is composed of specialized clinician-scientists in pediatrics, maternal fetal medicine, and specialties that care for immunocompromised hosts. Here we summarize the role of the VTEU in the investigation of the safety and efficacy of vaccines and therapeutics in vulnerable populations, including children, pregnant women, the elderly, and immunocompromised individuals.
Read the paper
Related studies
- Structural and topological analysis of thiosemicarbazone-based metal complexes: computational and experimental study of bacterial biofilm inhibition and antioxidant activity
- Toward better cures for Mycobacterium abscessus lung disease
- Challenges for global antibiotic regimen planning and establishing antimicrobial resistance targets: implications for the WHO Essential Medicines List and AWaRe antibiotic book dosing
- Design, Synthesis and In vitro Antitubercular Effect of New Chalcone Derivatives Coupled with 1,2,3‐Triazoles: A Computational Docking Techniques
- Upregulation of pmrA, pmrB, pmrC, phoQ, phoP, and arnT genes contributing to resistance to colistin in superbug Klebsiella pneumoniae isolates from human clinical samples in Tehran, Iran
- Whole-genome sequencing of clinical isolates of Citrobacter Europaeus in China carrying blaOXA−48 and blaNDM−1
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.